These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11502530)

  • 21. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
    Gong JZ; Liu Y; Xu WF
    Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
    Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Babu YS; Bantia S; Elliott AJ; Montgomery JA
    J Med Chem; 2001 Dec; 44(25):4379-92. PubMed ID: 11728184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in anti-influenza agents with neuraminidase as target.
    Zhang J; Xu W
    Mini Rev Med Chem; 2006 Apr; 6(4):429-48. PubMed ID: 16613580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
    Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial design of avian influenza neuraminidase inhibitors containing pyrrolidine core with a reduced susceptibility to viral drug resistance.
    Rungrotmongkol T; Udommaneethanakit T; Frecer V; Miertus S
    Comb Chem High Throughput Screen; 2010 Mar; 13(3):268-77. PubMed ID: 20015013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics and free energy analysis of neuraminidase-ligand interactions.
    Bonnet P; Bryce RA
    Protein Sci; 2004 Apr; 13(4):946-57. PubMed ID: 15044728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.
    Venkatramani L; Johnson ES; Kolavi G; Air GM; Brouillette WJ; Mooers BH
    BMC Struct Biol; 2012 May; 12():7. PubMed ID: 22559154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase.
    Varghese JN; Smith PW; Sollis SL; Blick TJ; Sahasrabudhe A; McKimm-Breschkin JL; Colman PM
    Structure; 1998 Jun; 6(6):735-46. PubMed ID: 9655825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.
    Wen WH; Wang SY; Tsai KC; Cheng YS; Yang AS; Fang JM; Wong CH
    Bioorg Med Chem; 2010 Jun; 18(11):4074-84. PubMed ID: 20452227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza neuraminidase.
    Air GM
    Influenza Other Respir Viruses; 2012 Jul; 6(4):245-56. PubMed ID: 22085243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A QSAR study on influenza neuraminidase inhibitors.
    Verma RP; Hansch C
    Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acyl amino acid derivatives as novel inhibitors of influenza neuraminidase.
    Kondoh M; Furutani T; Azuma M; Ooshima H; Kato J
    Biosci Biotechnol Biochem; 1997 May; 61(5):870-4. PubMed ID: 9178564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity.
    Laborda P; Wang SY; Voglmeir J
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27845731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel acylhydrazone neuraminidase inhibitors.
    Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
    Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidase inhibitors as antiviral agents.
    Alymova IV; Taylor G; Portner A
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):401-9. PubMed ID: 16535861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
    Yan ZL; Liu AY; Wei XX; Zhang Z; Qin L; Yu Q; Yu P; Lu K; Yang Y
    Carbohydr Res; 2019 May; 477():32-38. PubMed ID: 30954773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.